Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human GABRD ELISA Kit (AC3837)
Cat.#: ASET-2426
Specifications
Description Human GABRD ELISA Kit allows for the in vitro quantitative determination of human GABRD concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1974 Rat p75 NGF Receptor ELISA Kit (AC3385) Quantitative inquiry ASET-1509 Rat PPAR gamma ELISA Kit (AC2920) Quantitative inquiry ASET-1869 Human Nogo ELISA Kit (AC3280) Quantitative inquiry ASET-1999 Chicken Neuropeptide Y ELISA Kit (AC3410) Quantitative inquiry ASET-2140 Rat Laminin ELISA Kit (AC3551) Quantitative inquiry ASET-1802 Human TMEM158 ELISA Kit (AC3213) Quantitative inquiry ASET-1255 Rat nNOS (neuronal) ELISA Kit (AC2666) Quantitative inquiry ASET-2072 Mouse GDF11 ELISA Kit (AC3483) Quantitative inquiry ASET-2309 Human NECL-1 ELISA Kit (AC3720) Quantitative inquiry ASET-1098 Human COLEC12 ELISA Kit (AC2509) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket